|Acute Kidney Injury (AKI)||Anemia|
|Chronic Kidney Disease (CKD)||Contrast Nephropathy|
|Cardiovascular Disease (CVD)||Diabetes|
|Lupus Nephritis||Peritoneal Dialysis|
Better preservation of residual kidney function with twice-weekly than thrice-weekly hemodialysis in the first year.
Model has adequate discrimination; has been validated in three independent cohorts.
Stenting may benefit patients with renal artery stenosis who have historically been excluded from modern clinical trials.
Graft survival was similar to that seen in concurrent single SCD kidney recipients
An SBP target of about 120-140 rather than below 140 mm Hg may be more beneficial.
Studies show integrated program effective for depression in patients with cancer.
For team-based care to succeed, physicians must be willing to delegate.
Analysis of self-monitoring, self-titration of meds in patients at high risk of cardiovascular disease.
Overweight or obese adults with risk factors should be referred for intensive behavioral counseling.
Study reveals circadian variation in phosphate, parathyroid hormone, and 25-hydroxyvitamin D levels in patients with end-stage renal disease.
Improved renal function may contribute to the decline in a glycoprotein that inhibits bone formation.
But negative result from Kronus ZnT8Ab Elisa Assay doesn't rule out disease, FDA warns.
Investigators used a novel algorithm to characterize this rare and often life-threatening disorder seen mostly in ESRD patients.
Patients are more likely to receive a kidney transplant and less likely to die than patients with end-stage renal disease from other causes.
Seniors taking atypical antipsychotic drugs are at higher risk of acute kidney injury.
Black female hemodialysis patients less likely to want living transplant; more likely to receive offer.
Proteinuria, hypertension, and obesity in adolescence independently predict development of end-stage renal disease.
The association is most pronounced in hypertensives, consumers of high-sodium diets, and older individuals.
Second review shows value in CKD with suspected ACS, limited by variable sensitivity/specificity.
Hemodialysis patients with a higher percentage of fat tissue respond better to erythropoiesis-stimulating agents.